pioneering pharmaceuticals

making pharmaceuticals more affordable, more available, and better than before

Innovative solutions along the entire pharmaceutical value chain
As part of the TIEFENBACHER GROUP, a 100% family-owned leading health care company, we provide solutions throughout the entire life cycle of a pharmaceutical product. We develop, manufacture, and register innovative as well as generic drugs for our B2B customers. The world´s most trusted brands count on our high excellence in creating best-in-class-dossiers and our ability to manage complex launches in over 80 countries worldwide. Our own laboratories and manufacturing sites empower us to build up efficient supply chains resulting in best value for money for our customers.
There is one purpose driving TIEFENBACHER´s over 600 employees day by day: improving the life of millions of patients worldwide by making pharmaceuticals more affordable, more available, and better than before.

Best Value: affordable high-quality pharmaceuticals worldwide

Our Business Model: From initial idea to patient

We, at TIEFENBACHER PHARMACEUTICALS, develop, manufacture, and register innovative as well as generic drugs and license them out to marketing partners worldwide. Advance tomorrow’s medicine with us!

AET TIEFENBACHER PHARMACEUTICALS, a part of TIEFENBACHER GROUP: With purpose for people

We are pioneering healthcare to improve patients' lives around the world

Living our purpose – it gives meaning to everything we do

We believe that the global access to affordable high-quality healthcare is a human right. That’s why we are lead in everything we do by three questions: are we making high-quality pharmaceuticals better affordable, better globally available, and better than before? This clear purpose has deep and enduring value. It gives us the reason to come to work every day and reminds us why we exist as a company – to make a change in tomorrow ́s health.

Better Affordability

Better Global Availability

Better Therapy

Better Affordability

Better Global Availability

Better Therapy

Tiefenbacher Group: Organization structure

Best-in-class solutions along the entire pharmaceutical value chain

To achieve our purpose – to improve patients ́ lives worldwide – we have an agile, vertically integrated company structure. From initial idea to market access: We constantly look for smart and better ways to excel – to achieve solutions for current and future unmet needs. Our 100% family- owned company structure enhances the power of each individual division and enables us to respond quickly to the evolving demands of the market. Our broad competence allows us to connect ideas and expertise to create novel, patient-centric healthcare solutions and to bring them extremely fast to patients. This agile and vertically integrated organization structure empowers us to pioneer healthcare holistically.

Tiefenbacher Group: Organization structure

Best-in-class solutions along the entire pharmaceutical value chain

To achieve our purpose – to improve patients ́ lives worldwide – we have an agile, vertically integrated company structure. From initial idea to market access: We constantly look for smart and better ways to excel – to achieve solutions for current and future unmet needs. Our 100% family- owned company structure enhances the power of each individual division and enables us to respond quickly to the evolving demands of the market. Our broad competence allows us to connect ideas and expertise to create novel, patient-centric healthcare solutions and to bring them extremely fast to patients. This agile and vertically integrated organization structure empowers us to pioneer healthcare holistically.

Our company values: curiosity driven – excellence focused – patient centered

The courage to shape a better future
Always one step ahead – this is how we work, this is how we think

Our values define who we are and what special attitudes we have as individuals and together as an organization to achieve our purpose. They guide us in all we do. 

We believe that our expertise has to be leveraged for greater good – to improve patients’ lives worldwide. Our three values are central to how we behave as individuals, and collectively as an organization to achieve our purpose by making high-quality pharmaceuticals more affordable more available, and better than before.
We, within the evolved international TIEFENBACHER company structure, are many, working as one across functions, across companies, and across the world.
Our purpose and our values tie us together as a company and drive us to keep aiming for making an impact: from initial idea to market access – providing best-in-class solutions along the entire pharmaceuticals value chain. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-function structures, we tap into our full potential and stay at the forefront of our field.

Our three values in action mean:

Curiosity
Driven

Achiever by pioneership

>

Excellence focused

Know-How by enthusiasts

>

Patient
centered

Value by Innovations

>

Pioneership

Achiever
by curiosity

>

Excellence

Know-How
by enthusiasts

>

Patient Focus

Value by
Innovations

>

Our history: Pioneering Healthcare since 1963

Over 55 years track record of industry firsts

From a distributor of Active pharmaceutical Ingredients (APIs) to a purpose-driven healthcare company with a global footprint.  

Founded in 1963 as the world’s first exclusive agency for active pharmaceutical ingredients (APIs), Tiefenbacher has been grown into a leading healthcare company providing innovative and best-in-class solutions along the entire pharmaceutical value chain. Representing API producers has provided the foundation for Tiefenbacher´s growth into an international operating, vertically integrated pharmaceutical company. From initial idea to market access: Today we distribute APIs and develop, manufacture, and register finished dosage forms (FDFs) as well as medical devices. In over 55 years of our company history, we have shown an outstanding track record in anticipating new developments as well as launching new businesses

Our history: Pioneering Healthcare since 1963

Over 55 years track record of industry firsts

From a distributor of Active pharmaceutical Ingredients (APIs) to a purpose-driven healthcare company with a global footprint.  

Founded in 1963 as the world’s first exclusive agency for active pharmaceutical ingredients (APIs), Tiefenbacher has been grown into a leading healthcare company providing innovative and best-in-class solutions along the entire pharmaceutical value chain. Representing API producers has provided the foundation for Tiefenbacher´s growth into an international operating, vertically integrated pharmaceutical company. From initial idea to market access: Today we distribute APIs and develop, manufacture, and register finished dosage forms (FDFs) as well as medical devices. In over 55 years of our company history, we have shown an outstanding track record in anticipating new developments as well as launching new businesses

From a local distributor to a global healthcare play

AT A GLANCE: OUR MILESTONES AND GONTINUED GROWTH AT TIEFENBACHER GROUP

We have always been powered by a strong commitment to make a difference with our products and services – for the benefit of patients worldwide. Since 1963 we are pioneering healthcare to improve patients’ lives around the world. Please have an overview about our milestone and how we, TIEFENBACHER GROUP, are pioneering healthcare – and contribute to people for a better tomorrow.

Preloader

  • Foundation by Alfred E. Tiefenbacher in Hamburg

    Foundation by Alfred E. Tiefenbacher in Hamburg

  • 3rd Employee

    3rd Employee

  • Move to new address in villa on Harvestehuder Weg

    Move to new address in villa on Harvestehuder Weg

  • First generic drug development of finished dosage form (FDF)

    First generic drug development of finished dosage form (FDF)

  • First EU marketing authorization under own name

    First EU marketing authorization under own name

  • Move to new headquarters at port of Hamburg

    Move to new headquarters at port of Hamburg

  • Opening of AET Labs (India)

    Opening of AET Labs (India)

  • Acquisition of Delorbis Pharmaceuticals manufacturing site (Cyprus)

    Acquisition of Delorbis Pharmaceuticals manufacturing site (Cyprus)

  • Celebration of the 50th anniversary of Tiefenbacher Group

    Celebration of the 50th anniversary of Tiefenbacher Group

  • Foundation of AET Medical Products

    Foundation of AET Medical Products

  • First NCE submission under own name

    First NCE submission under own name

  • FDA approval of AET Labs manufacturing site

    FDA approval of AET Labs manufacturing site

  • First FDF US submission under own name

    First FDF US submission under own name

  • First medical device CE certification

    First medical device CE certification

Our founder Alfred E. Tiefenbacher

Pioneer of the pharmaceutical industry

Our entrepreneurial spirit is firmly anchored in our founder and owner family since 1963.

The foundation of TIEFENBACHER GROUP´s success story was the pioneer spirit of the company´s founder and namesake Alfred E. Tiefenbacher (*1917, +1993). Until today his unique entrepreneur mind is our driving force of achieving better health solutions by always challenging the status quo – in terms of business models as well as concrete products and services.

AET TIEFENBACHER PHARMACEUTICALS Management

our managing directors

AET, as a part of the TIEFENBACHER GROUP, is led by a seasoned team of executives. Their cumulative knowledge and combined professional backgrounds add up to unparalleled leadership that keeps our company always a step ahead of the industry and in sync with our purpose to improve patients’ live around the world.

Dr. Kristian Ruepp

Kristian has held various positions in the pharmaceutical industry. He was able to contribute to the development, production, and control up to the international marketing of pharmaceuticals – recently as managing director of an internationally operating pharmaceutical company. Kristian joined Alfred E. Tiefenbacher in 2018 and is responsible for the pharmaceutical functions and marketing. 

Kristian is married and father of three. 

Oliver Schrader

Oliver spent the vast majority of his global career in the branded consumer goods industry. Besides leading functions in marketing and sales he served as managing director of German Dax and skin care company Beiersdorf in Ukraine, South Africa and North America. Oliver joined the TIEFENBACHER GROUP in 2016 and is overlooking all commercial topics. 

Oliver is married and a father of three. 

Dr. Kristian Ruepp

Kristian has held various positions in the pharmaceutical industry. He was able to contribute to the development, production and control up to the international marketing of pharmaceuticals – recently as managing director of an internationally operating pharmaceutical company. Kristian joined Alfred E. Tiefenbacher in 2018 and is responsible for the pharmaceutical functions and marketing. 

Kristian is married and father of three. 

Oliver Schrader

Oliver spent the vast majority of his global career in the branded consumer goods industry. Besides leading functions in marketing and sales he served as managing director of German Dax and skin care company Beiersdorf in Ukraine, South Africa and North America. Oliver joined the TIEFENBACHER GROUP in 2016 and is overlooking all commercial topics. 

Oliver is married and a father of three. 

Global Presence –
in over 80 countries

TIEFENBACHER PHARMACEUTICALS is making medicines more affordable, more available, and better than before.

Tiefenbacher Group

Webcam Hamburg

Contact – AET TIEFENBACHER PHARMACEUTICALS

As the builders of the future, we are working to improve people´s lives worldwide. By thinking beyond healthcare we are making medicines more affordable, more available, and better than before.
Please contact us by filling out the contact form below and clicking “Send message”, or directly send an email to info@aet.eu. AET TIEFENBACHER PHARMACEUTICALS will follow up with you personally as soon as possible.

    ALFRED E. TIEFENBACHER (GmbH & Co. KG)
    Van-der-Smissen-Strasse 1
    22767 Hamburg
    Germany

    Phone: +49 40 – 44 18 09 – 0
    Fax: +49 40 – 44 18 09 – 26
    Mail: info@aet.eu

    Pioneership

    Achiever by curiosity

    ×
    • We are always challenging the status quo and striving for new patient orientated solutions – in terms of business models as well as concrete products and services for our customers and partners.
    • We believe that the basis for our innovation power is curiosity – the curiosity of each of our employees dedicated to make patients´ life better.
    • This entrepreneurial spirit is firmly anchored in our founder and owner family since 1963 – making us a health pioneer.

    Excellence

    Know-how by Enthusiasts

    ×
    • Our experience of almost 60 years in the pharmaceutical industry and the constant development of our group allow us to deliver premium value to our customers and partners along the whole pharmaceutical supply chain.
    • The world most trusted brands count on our high excellence in research and development and reliable quality assurance building the foundation for our broad and innovative product portfolio.
    • Our strong track record in gaining international marketing authorizations in 80+ countries leads to a global availability of our high-quality developments.
    • We drive efficiency by keeping our supply chains simple and reaching economies of scales in our own manufacturing sites resulting in best value for money for our customers.
    • About 600 highly skilled employees worldwide and a unique global network of partners are the key for our high level of excellence.

    Patient Focus

    Value by Innovations

    ×
    • All our activities are focused on making patients´ lives better by creating pharmaceuticals more available, more affordable, and better than before.
    • We believe that high-quality medicine should be affordable and available to everyone – irrespective of their income, their origin or their nationality.
    • We also believe that there are always new ways of smart medicines which better deliver on patients´ needs.
    • To better understand patients´ needs we are in close and regularly collaboration with universities and key opinion leaders of all relevant disciplines.